salsoline has been researched along with propargylamine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Maruyama, W; Naoi, M | 1 |
| Akao, Y; Iwasa, K; Maruyama, W; Naoi, M; Takahashi, T; Yi, H; Youdim, MB | 1 |
1 review(s) available for salsoline and propargylamine
| Article | Year |
|---|---|
[Studies on endogenous toxins as pathogenic factors in idiopathic parkinson's disease].
Topics: Aging; Animals; Apoptosis; Dopamine; Humans; Methyltransferases; Mitochondria; Neurotoxins; Pargyline; Parkinson Disease; Propylamines; Salsoline Alkaloids; Tetrahydroisoquinolines | 2000 |
1 other study(ies) available for salsoline and propargylamine
| Article | Year |
|---|---|
N-Propargylamine protects SH-SY5Y cells from apoptosis induced by an endogenous neurotoxin, N-methyl(R)salsolinol, through stabilization of mitochondrial membrane and induction of anti-apoptotic Bcl-2.
Topics: Apoptosis; Apoptosis Regulatory Proteins; Dose-Response Relationship, Drug; Humans; Mitochondria; Mitochondrial Membranes; Neuroprotective Agents; Pargyline; Propylamines; Proto-Oncogene Proteins c-bcl-2; Salsoline Alkaloids; Tetrahydroisoquinolines; Tumor Cells, Cultured | 2006 |